Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice

Understanding the underlying properties-dependent interactions of nanostructures with biological systems is essential to nanotoxicological research. This study investigates the relationship between particle size and toxicity, and further reveals the mechanism of injury, using silica particles (SP) with diameters of 30, 70, and 300 nm (SP30, SP70, and SP300) as model materials. The biochemical compositions of liver tissues and serum of mice treated with SP30, SP70, and SP300 were analyzed by integrated metabonomics analysis based on gas chromatography-mass spectrometry (GC-MS) and in combination with pattern recognition approaches. Histopathological examinations and serum biochemical analysis were simultaneously performed. The toxicity induced by three different sizes of SP mainly involved hepatocytic necrosis, increased serum aminotransferase, and inflammatory cytokines. Moreover, the toxic effects of SP were dose-dependent for each particle size. The doses of SP30, SP70, and SP300 that were toxic to the liver were 10, 40, and 200 mg kg(-1), respectively. In this study, surface area has a greater effect than particle number on the toxicity of SP30, SP70, and SP300 in the liver. The disturbances in energy metabolism, amino acid metabolism, lipid metabolism, and nucleotide metabolism may be attributable to the hepatotoxicity induced by SP. In addition, no major differences were found in the response of biological systems caused by the different SP sizes among the metabolite profiles. The results suggest that not only nano-sized but also submicro-sized SP can cause similar extents of liver injury, which is dependent on the exposure dose, and the mechanism of toxicity may be almost the same.

[1]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[2]  K. Audus,et al.  Microparticulate uptake mechanisms of in‐vitro cell culture models of the respiratory epithelium , 2001, The Journal of pharmacy and pharmacology.

[3]  David M. Brown,et al.  Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.

[4]  Mina Choi,et al.  The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. , 2009, Toxicology letters.

[5]  K. Wittmaack In Search of the Most Relevant Parameter for Quantifying Lung Inflammatory Response to Nanoparticle Exposure: Particle Number, Surface Area, or What? , 2006, Environmental health perspectives.

[6]  Tao-Tao Liu,et al.  Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  Ian D Wilson,et al.  Analytical strategies in metabonomics. , 2007, Journal of proteome research.

[8]  W. MacNee,et al.  Role of transcription factors in inflammatory lung diseases , 1998, Thorax.

[9]  A. Tas,et al.  Sensitivity of (1)H NMR analysis of rat urine in relation to toxicometabonomics. Part I: dose-dependent toxic effects of bromobenzene and paracetamol. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[11]  Qian Bu,et al.  NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration , 2010, Nanotechnology.

[12]  Agnes G Oomen,et al.  What do we (need to) know about the kinetic properties of nanoparticles in the body? , 2007, Regulatory toxicology and pharmacology : RTP.

[13]  Weimin Song,et al.  Pulmonary responses to fine particles: differences between the spontaneously hypertensive rats and wistar kyoto rats. , 2007, Toxicology letters.

[14]  J R Griffiths,et al.  Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies , 1998, Magnetic resonance in medicine.

[15]  Kieran Clarke,et al.  A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. , 2006, Physiological genomics.

[16]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[17]  R M Albrecht,et al.  Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.

[18]  Alan Aderem,et al.  Phagocytosis and the inflammatory response. , 2003, The Journal of infectious diseases.

[19]  W. Chan,et al.  Nanotoxicity: the growing need for in vivo study. , 2007, Current opinion in biotechnology.

[20]  C. M. Galhardi,et al.  Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  Minbo Lan,et al.  Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  V. Colvin The potential environmental impact of engineered nanomaterials , 2003, Nature Biotechnology.

[23]  T. Xia,et al.  Impairment of mitochondrial function by particulate matter (PM) and their toxic components: implications for PM-induced cardiovascular and lung disease. , 2007, Frontiers in bioscience : a journal and virtual library.

[24]  Qingxiu Wang,et al.  Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity. , 2008, Toxicology and applied pharmacology.

[25]  E Holmes,et al.  The mechanism of galactosamine toxicity revisited; a metabonomic study. , 2007, Journal of proteome research.

[26]  J. Nakanishi,et al.  Comparative pulmonary toxicity study of nano-TiO(2) particles of different sizes and agglomerations in rats: different short- and long-term post-instillation results. , 2009, Toxicology.

[27]  P. Watkins Biomarkers for drug-induced liver injury , 2010 .

[28]  P. So,et al.  Metabolic effects of citrate in liver during cold hypoxia studied by 1H NMR spectroscopy. , 1998, Cryobiology.

[29]  J. Pounds,et al.  Macrophage responses to silica nanoparticles are highly conserved across particle sizes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  J. Fuscoe,et al.  Effect of (+)-usnic acid on mitochondrial functions as measured by mitochondria-specific oligonucleotide microarray in liver of B6C3F1 mice. , 2009, Mitochondrion.

[31]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[32]  H. Karlsson,et al.  Size-dependent toxicity of metal oxide particles--a comparison between nano- and micrometer size. , 2009, Toxicology letters.

[33]  Stephen J. Bruce,et al.  Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. , 2005, The Analyst.

[34]  W. MacNee,et al.  The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area , 2007, Occupational and Environmental Medicine.

[35]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[36]  Pratim Biswas,et al.  Does nanoparticle activity depend upon size and crystal phase? , 2008, Nanotoxicology.

[37]  Sung Jun Kim,et al.  Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. , 2007, Toxicology letters.

[38]  Scott C. Brown,et al.  Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  Yasuo Tsutsumi,et al.  Silica nanoparticles as hepatotoxicants. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.